Recombinant Salmonella paratyphi A Cardiolipin synthase (cls)

Basic Research Questions

What is the functional role of Cls in Salmonella Paratyphi A metabolism?

Cls (cardiolipin synthase) catalyzes the synthesis of cardiolipin (CL), a structurally unique phospholipid critical for bacterial membrane integrity, stress adaptation, and virulence. In S. Paratyphi A, ClsB (a paralog of ClsA/C) has been shown to synthesize 6-phosphatidyltrehalose (PT) and 6,6'-diphosphatidyltrehalose (diPT)—novel trehalose-containing phospholipids that activate the human immune receptor Mincle . Methodological considerations:

• Gene deletion studies: ΔclsB mutants exhibit loss of PT/diPT production but retain CL synthesis via ClsA/C .

• Lipidomics: Use HPLC-MS to profile lipid extracts from wild-type vs. mutant strains .

How does ClsB differ from other cardiolipin synthases in Salmonella?

ClsB has unique substrate promiscuity compared to ClsA (primary CL synthase) and ClsC (stationary-phase CL synthase) :

Experimental validation:

• In vitro assays: Purify recombinant ClsB and test activity with radiolabeled substrates .

• TLC/MS analysis: Compare lipid profiles of ΔclsA/B/C mutants .

Advanced Research Questions

What experimental strategies resolve contradictions in ClsB functional annotation?

Early studies misannotated ClsB as a CL synthase due to sequence homology. Discrepancies arise because:

• ClsB produces PT/diPT as primary products in S. Typhi but not in E. coli .

• CL synthesis in S. Paratyphi A is ClsA-dependent, with ClsB contributing minimally under standard conditions .
  Resolution approaches:

• Chemotyping: Lipid profiling (HPLC-MS) outperforms phylogenetic analysis of clsB sequences .

• Heterologous expression: Express S. Paratyphi A clsB in E. coli Δcls strains to test product specificity .

How do PT/diPT biosynthesis pathways inform vaccine adjuvant design?

PT/diPT activate Mincle, a macrophage receptor also triggered by mycobacterial cord factor . This functional convergence suggests:

• Adjuvant potential: DiPT could substitute trehalose dimycolate (TDM) in subunit vaccines.

• Biosynthesis hurdles: Low diPT yields in recombinant systems require optimization:

  • Codon-optimize clsB for expression in E. coli .

  • Use T7 promoter systems with induction at OD₆₀₀ = 0.6–0.8 .

What genomic tools exist for studying cls in S. Paratyphi A outbreaks?

The Paratype genotyping framework identifies cls variants across 18 genotypes :

Application:

• Phylogenetic mapping: Use RAxML with SNP alignments from 1,379 genomes .

• CRISPR interference: Knock down clsB in outbreak strains to assess lipidome changes .

Methodological Challenges & Solutions

How to optimize recombinant ClsB expression for structural studies?

Challenges:

• Membrane protein instability (50% loss in 24h at 4°C) .

• Low solubility in E. coli (~15% in soluble fraction) .
  Solutions:

• Expression vector: Use pET-28a with N-terminal His-tag and tobacco etch virus (TEV) site .

• Detergent screening: Test n-dodecyl-β-D-maltopyranoside (DDM) vs. lauryl maltose neopentyl glycol (LMNG) .

Why do lipidomics studies yield conflicting ClsB activity data across Salmonella serovars?

Discrepancies arise from:

• Serovar-specific regulation: S. Typhi produces 9x more diPT than S. Paratyphi A .

• Growth conditions: Stationary-phase cultures upregulate ClsB 4-fold .
  Standardization protocol:

• Culture strains to OD₆₀₀ = 2.0 in LB + 0.5% glucose.

• Extract lipids using Bligh-Dyer method with 2:1:0.8 CHCl₃:MeOH:H₂O .

Data Interpretation Frameworks

How to validate ClsB's immune activation role in murine models?

Experimental design:

• Wild-type vs. ΔclsB: Inject C57BL/6 mice (n=10/group) with 10⁶ CFU; measure IFN-γ via ELISA .

• diPT purification: Isolate from S. Typhi ΔclsA mutant .

• Mincle^-/- controls: Confirm receptor specificity .

What systems biology approaches integrate ClsB data with multi-omics datasets?

• Metabolite correlation: Map diPT levels to transcriptomic data (e.g., phoPQ activation) .

• Machine learning: Train random forest models on lipidomic profiles to predict strain virulence .

Ethical & Safety Considerations

What biosafety protocols apply to recombinant cls studies?

• Containment: BSL-2 for S. Paratyphi A ΔclsB mutants .

• Antibiotic resistance: Avoid ampicillin markers; use kanamycin (50 μg/mL) for plasmid selection .